Vascular dementia is the 2nd leading cause of dementia in the UK and there are currently no proven treatments. A new study at the University of Southampton is now investigating whether a failure of fluid drainage along the walls of blood vessels in the brain is a cause of vascular dementia.
Co-funded by the Stroke Association, and published in the International Journal of Stroke, research suggests a new tool can better predict what level of memory and thinking (cognitive) problems patients will experience after stroke, than more time consuming methods.
PRESTIGE-AF is a new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Can stem cells be used to reduce the damage of inflammation after stroke and promote brain repair?
This project aims to demonstrate that failure of drainage of fluid from the grey and white matter of the brain is a mechanism underlying Small Vessel Disease, a condition that affects the small blood vessels in the brain which can cause stroke and dementia.
This study will test arm training to encourage a functionally useful contribution to recovery from the side of the brain unaffected by stroke (the 'non-stroke hemisphere'), and whether this is only possible early after stroke.
In this study, we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
Using transcranial magnetic stimulation (TMS) to enable activation of the damaged part of the brain to be more active in the recovery period after a stroke
Can an anti-inflammatory drug (IL-1Ra) given into the skin reduce damaging inflammation in the brain and body after stroke compared to a dummy-drug?